Some reports observed markedly elevated IL-5 levels in active SLE patients, correlating with anti-nuclear antibody titers (38, 39), while a larger multicenter cohort identified IL-5 upregulation in only 32% of patients, without a clear association with SLEDAI scores (40). This evidence concerns the gene IL5 and systemic lupus erythematosus.